Coronavirus | Opeds and editorials

Vigilance, vaccination and endemic COVID-19

On June 27, 2021, the daily reported COVID-19 cases (seven-day rolling average) had fallen below 50,000, and have remained so for 15 consecutive weeks (Worldometer – Corona-India). That heralded the end of the second wave of India’s epidemic and marked its transition to ‘endemic’ state. It fell below 40,000 on September 9, and below 30,000 on September 24. The trend continues.

Population and infection

Endemic denotes steady weekly numbers without major fluctuations. Fifteen weeks of this trend spells consistency. Kerala, Sikkim, Mizoram and Meghalaya are outliers/exceptions to the national endemic state — they have not yet transitioned to endemic phase (covid19india.org) but their daily case-trends show they will soon catch up and become endemic. Country-level endemicity indicates that the vast majority of the population is already infected and immune, but how large is the majority?

 

The fourth ICMR sero-survey (June-July 2021) showed 67.6% had antibodies by end July — that is roughly 950 million. The reported cumulative COVID-19 cases by end-July were 30,410,577 (3.2 % of 950 million). So, actual infections were ~30 times the reported number. From August 1 to October 7 — 2,219,097 additional cases were reported, representing, by extrapolation, 70 million infections, taking the total to 1,020 million, the susceptible population therefore is 1,400 - 1,020 = 380 million. The Indian Council of Medical Research (ICMR) found, in the second sero-survey, that detected antibody prevalence underestimates true immunity prevalence, detecting only ~70% of those who were RT-PCR positive earlier, therefore the susceptible pool may be much smaller.

Endemic transmission will be sustained by new infections in previously uninfected remnants plus new additions to population by annual birth cohorts of 25 million (less mortality) and by re-infections in those previously infected.

The second wave of the pandemic was driven by the Delta variant, with a basic reproduction number (Ro) of 6-8. The epidemiology formula (1—1/Ro) is used to calculate the herd immunity threshold (HIT) necessary to end the epidemic, which is ~87.5%, in our estimations. Applying the principle of triangulation this observation corroborates the fact of epidemic-endemic transition.

 

On the jab

India rolled out its COVID-19 vaccines on January 16, 2021, but the pace of vaccination is slow, 20% having received two doses (2.2% per month). So, the major contributor to reaching HIT was natural infection in two waves. Two recent preprints, one from Christian Medical College Hospital Vellore and the other from Israel indicate that infection-induced immunity confers greater protection than vaccination. Thus, India’s immune population has good short-term protection against re-infection and disease. Indeed, the reinfection rate in India according to the ICMR was only 4.5%.

India’s COVID-19 control strategy, hitherto addressing epidemic COVID-19, has to be modified now for endemic COVID-19. Two important factors will dictate the modifications: Senior citizens, those with co-morbidity/cancer treatment/organ transplant, etc. and pregnant women, who had not been infected in the past or not yet vaccinated with two doses, would have risks of severe disease, need for hospitalisation, admission in an intensive care unit, and mortality. They have to be traced individually and vaccinated.

More by re-infections

Endemic transmission will be driven more by re-infections than by first infections. A paper in The Lancet Microbe, October 1, reported the durability of immunity against re-infection in coronavirus infections, the profiles of antibody decline and probabilities of re-infection over time, under endemic conditions. Re-infection is likely three months to 5·1 years after peak antibody response, median 16 months. Hence, all previously infected but unvaccinated persons require at least one dose of the vaccine.

 

Studies have shown that those who had natural infection may need only one dose of any approved vaccine to stimulate long-lasting immunity even against reinfection. A meticulous follow-up study of antibody levels in those who had infection is urgently needed to determine when such individuals will need a booster dose. Their immune response profile to one dose of different vaccines also needs to be documented.

Persons previously uninfected but vaccinated with two doses have to be given a booster dose of vaccine to offer protection against breakthrough re-infection. Immunology informs that the optimum time interval for a booster dose is six months to one year after the previous dose. We must monitor both the immune response levels and durability post-booster. Such data will then guide if and when any further booster(s) may be required.

Contact tracing, testing and quarantine requirements — very important during an epidemic spread — will now have to be confined to the elderly and vulnerable contacts so as to facilitate early recognition and treatment of COVID-19, rather than for everyone. Our two-dose vaccination coverage should be rapidly escalated — the current weekly rate of about 0.6% of the population given a second dose, is too slow and must be revved up — through intensive information-education-communication and by vaccination campaigns.

 

Vaccination should be targeted for the purposes of re-opening all schools and hubs of economic activities. The entire work force in India (organised, unorganised, self-employed, those in the travel and tourism industry) need to be targeted for vaccination; this is best done at the workplace with the help of the respective managements and State health authorities. Thereafter, all social, religious, cultural and recreational gatherings can be allowed.

Childhood infection

Childhood infection with the coronavirus is mostly mild and self-limiting as children have lower density of the ACE2 receptor (the portal of cell-entry of virus) in their respiratory passages. Multi-system-inflammatory syndrome, a severe complication encountered in children, is fortunately very rare and treatable. Under these circumstances, children are best protected by fully immunising all school personnel (teachers, non-teaching staff, transport) and all eligible subjects at home, thereby creating a protective mantle.

After any vaccine gets approved for use in children, (Covaxin and ZyCoV-D may be approved soon), they can be immunised – the easiest way forward would be school-based vaccination camps.

 

Continued endemic transmission is the opportunity to progressively relax restrictions of social contacts, but such return to normalcy must be under the umbrella of vaccination (as detailed above) and universal mask use. When endemicity is sustained over a longer time, seasonal outbreaks (minor waves) must be anticipated — but even they can be averted by vaccination. Vigilance cannot be let down until we ensure that no one remains at risk of severe COVID-19.

Dr. T. Jacob John is a retired professor of Clinical Virology, Christian Medical College, Vellore, Tamli Nadu and former President of the Indian Academy of Pediatrics. Dr. M.S. Seshadri is a retired Professor of Medicine and Clinical Endocrinology, Christian Medical College, Vellore, and currently Medical Director, Thirumalai Mission Hospital Ranipet, Tamil Nadu


Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Dec 9, 2021 9:00:00 AM | https://www.thehindu.com/opinion/op-ed/vigilance-vaccination-and-endemic-covid-19/article37013327.ece

In This Package
A measured response: On the Omicron threat
Boosters short: On third COVID-19 vaccination dose
The Omicron response is not making sense
Limited gains: On Omicron risk
Scale up supplies: On Omicron variant
What the Omicron variant means for India
Learning from the best in India’s COVID-19 fight
Focus on full vaccination: On India’s COVID-19 inoculation pace
India needs to sign up for life-course immunisation
Strengthening vaccine trust
A reminder from SARS-CoV-2
The vaccination milestone and a distant goal
Responding to adversity with achievement
Scripting history: On 100 crore COVID-19 vaccine doses
You are reading
Vigilance, vaccination and endemic COVID-19
A flicker of hope: On declining COVID-19 numbers
Vital relief: On COVID-19 death compensation
A spike: On records and COVID-19 vaccination coverage
Cracking the whip: On Joe Biden’s vaccine mandates
Should children be given COVID-19 jabs?
The lag between jabs: On Covishield gap
Back at school: On student safety
Breakthrough challenge: On vaccines and the virus variants
The prognosis for school reopenings
Effectiveness of vaccines
Kerala’s rising COVID-19 cases explained
Learning safely: On schools reopening
A surfeit of sero surveys
Curbing Delta: On the variant that drives India’s COVID-19 infections
Focusing on diseases sidelined by COVID-19
Lessons from India’s all-cause mortality data
Safe at school: On getting students back on campus
The importance of the booster dose to plan ahead
A call for improving civil registration systems
Pandemic of distrust: On resisting COVID-19 vaccination
Vaccinating the young: On priority groups
A serosurvey template for the whole of India
Making decisions under stress
Dealing with denial: On playing down the COVID-19 tragedy
A cardinal omission in the COVID-19 package
Rising again: On global rise of fresh COVID-19 cases
Ramping up supply: On COVID-19 vaccination woes
Upholding trust in vaccination
Caution and optimism: On preventing the third wave
Countering the next wave of COVID-19
Stopping the surge: On unlock and the next COVID-19 wave
A welcome spike: On India’s COVID-19 vaccination record
A time to give: On ex-gratia compensation to families of COVID-19 victims
Focus on COVID-19 estimated deaths
What needs to be done with vaccines
Counting the dead: On measuring excess deaths
Refocused vaccination campaigns are possible
Bring genomic sequencing into the pandemic fight
Preparing for the next COVID-19 wave
Connecting the dots to mitigate a third wave
The red flags on the trail of the virus
Behaviorial change can reduce transmission
Adverse changes, federalism imperilled
Close the vaccination gap, in global lockstep
Only a global effort can tame COVID-19
Addressing vaccine hesitancy
Naturally, selection: On vaccinating the vulnerable in 18+ group
Vaccination is our only weapon
Extending safety: On deferring second dose of COVID-19 vaccine
The AIDS fight offers a COVID vaccine patent pathway
The basics of an effective vaccine policy
Using all options: On Covaxin licensing
State action: On Centre’s role in COVID-19 fight
COVID mishandling foretold in the Budget
A matter of concern: On Indian coronavirus variant
Vaccine skirmishes: On production of COVID-19 vaccine
Lockdown gains: On need to augment health system
Social murder and the missing state
A CT scan for COVID merits a word of caution
To stop a third wave, India has to mask up
Is the government committed to vaccine equity?
Salutary steps: On Election Commission norms to curb COVID-19 spread
Shortage and wastage: On cutting vaccine wastage
Gasping for air, gasping for answers
Misinformed and misleading
Right priorities: On U.S. COVID-19 aid to India
A patently wrong regime
Tips for managing COVID-19 at home: the dos & don’ts
Undermining ‘vaccination for all’
Another wave spells more nutrition loss
Unfair and dangerous: On vaccine inequity
Viral load: On lockdowns, lives and livelihoods
The road ahead in India’s augmented vaccination drive
Infernal infernos: On hospital fires amid the pandemic
Too little: On the Election Commission’s COVID-19 curbs
India’s COVID crisis — when difficult became worse
A descent into disillusionment and chaos
Open and safe: On Modi government’s vaccination policy
A recipe for vaccine inequity
Vaccine diplomacy that needs specific clarifications
On the trail of the second wave’s dynamics
How can India contain the second wave?
Lessons from the first wave
Examination priorities: On annual exams amid the pandemic
The secrecy around deaths after vaccination
Indian universities need immediate vaccination
Lessons from COVID-19
The second wave: On why new COVID-19 vaccines should be cleared
Weighing in on the saga of a vaccine
Rising poverty: On pandemic-induced disparities
A booster shot for India’s vaccination plan
Allaying concerns: On public trust and vaccination programmes
A moral test: On the vaccine divide
Efficacious too: On Covaxin
Sustaining the drive: On COVID-19 vaccination phase 2
Vaccine inequities: On need to vaccinate all above 45
Addressing vaccine reluctance and policy hesitancy
Redefining the exit plan for COVID-19
Boosting confidence: On need for efficient use of COVID-19 vaccine stocks
Opening up the vaccine market
Origin and spread: On the source of SARS-CoV-2
New questions: On COVID-19 infecting one-fifth of Indian population
A year on, mind the gaps in the pandemic response
Should Board exams be conducted in one go this year?
No to vaccine nationalism, yes to global cooperation
Tempered optimism: On India’s sliding COVID-19 graph
The best shot against COVID-19
More vaccines than takers
Managing the rollout: On addressing vaccine hesitancy
Injecting confidence: On India’s COVID-19 vaccination drive
Vaccine optimism and the scientific uncertainty link
Building trust in vaccines
The debilitating side-effect of a flawed vaccine trial
Gearing up: On vaccines and public trust
A hurried gamble: On vaccines and transparency
The second dose: On COVID-19 vaccine
A constant vigil: On the new coronavirus strain in India
Unmasked, reflections on the pandemic and life
Caution pays: On Centre’s COVID-19 surveillance guidelines
Towards an effective vaccination distribution policy
Essential dry run: On COVID-19 vaccination drive
COVID-19 and limits of political accountability
The purpose of a vaccine
Clear the fog, draw up a clear vaccination policy
Rein in the vaccine nationalism, the profiteering
In vaccine race last lap, the key steps for India
The storage tale of two vaccines
T-cell immunity and COVID-19
COVID-19, climate and carbon neutrality
Signs of easing: On India’s COVID-19 fight
Has India passed the COVID-19 peak?
Sooner, better: On indigenously developed COVID-19 test kits
The battered Puja economy
Outline of a pandemic fight, by and for citizens
Pandemics and the collective consciousness
Vaccines with a global common good guarantee
Saving lives under the long shadow of the pandemic
Until vaccine: On Unlock 5
The challenge of changing health behaviour
Weighing the costs: On COVID-19 vaccine
The slow and frustrating journey of recovering from COVID-19
Health worker safety deserves a second look
Unlocking campuses: On UGC’s revised academic calendar
Recovery from COVID-19 can be a struggle
Uniting to combat COVID-19
Coronavirus fears and preconception advice
An agriculture-led revival as flawed claim
A necessary pause: On the COVID-19 vaccine race
The uncertainties over COVID-19 numbers
The challenges in counting the dead
COVID-19 deaths may be higher than reported
The many challenges in estimating deaths
Alone at the top: On India’s COVID-19 numbers
The participants we need in Phase 3 trials
Differential impact of COVID-19 and the lockdown
More than a vaccine, it is about vaccination
COVID-19 and a country club India must leave
A quest for order amid cyber insecurity
Adopting a public systems approach to COVID-19
Milestone of a million: On India’s COVID-19 numbers
Testing times: On university exams
Predictions, pandemics and public health
It’s time to flatten the pandemic stereotyping
Viral outrage only spikes the data
Sending the right message
Needed: Clear testing data
The social contract needs to be rewritten
The pandemic is about eyes shut
Joblessness and opportunity in Tamil Nadu
Green-lighting ecological decimation amidst a pandemic
COVID-19 has no religion
A case for extension: On rural jobs scheme
Surely, even if slowly: On a COVID-19 vaccine
Bend it like Italy: On flattening the COVID-19 curve
Promise and delivery: On India’s first COVID-19 vaccine
States hold the key: On Unlock 2.0
PCR testing is a double-edged sword
Science vs nonsense: On Patanjali’s COVID-19 claim
Shut and open: On tennis during the pandemic
The perils of follow the leader syndrome
The many questions about Favipiravir
In new lockdown, a second chance for Tamil Nadu
United front in Delhi: On Kejriwal government-Centre camaraderie
A prescription of equitable and effective care
Multilateralism post COVID-19
Making public transport safe during COVID-19
A better rate: On COVID-19 recovery
Look back in relief: On the migrant labour crisis
Needed, a transfusion for public health care
Wrong priorities: On keeping religious places open during a pandemic
Crossing the line: On Delhi’s decision to limit health services
Profit, not profiteering: On regulation of COVID-19 testing charges
In Persian Gulf littoral, cooperative security is key
Paging the private sector in the COVID fight
Curves and recoveries: On India’s coronavirus numbers
India’s Parliament is missing in action
Axing the economy’s trunk
Scripting a new narrative for COVID control
Open with caution: On Unlock 1
It’s time for a universal basic income programme in India
The waning of subaltern solidarity for Hindutva
Export blocks: On India’s trade amid the pandemic
A moment to trust the teacher
The echo of migrant footfalls and the silence on policy
Enjoying the fruits of their labour
Helping supply chains recover
The heavy burden of social suffering
An effective lockdown
The lockdown has highlighted stark inequalities
Will sport be the same in empty stadia?
Cinema after COVID-19
The eternal longing for the distant home
Working safely: On workplaces during the pandemic
A hole in the whole: On health sector woes
China, better prepared for the post-COVID world
How public health boosts an economy
Keep it retrospective
Backing the ‘angels in white coats’
Standstill: On opening of stadia for training
Flawed stimulus is justice denied
We need social physicians
A callous response
Peaking: On India’s coronavirus tally
Farm gate in focus: On amending Essential Commodities Act
A question of quarantine: On migrant workers and other travellers
TASMAC tribulations: On Tamil Nadu liquor sale
The pandemic and the challenge of behaviour change
One for the poor: On Centre’s corona package
Lockdown syndrome: On virus-induced economic crisis
Are India’s labour laws too restrictive?
Stop the return to laissez-faire
States cannot be left to the Centre’s mercy
Local motif: On Modi’s call for self-reliance
Liquidity lifeline: On Nirmala’s MSME package
A plan to revive a broken economy
Provide income support, restore jobs
Perilous state: On State finances
COVID-19 and the path ahead
Reaffirm cooperative federalism
Riding roughshod over State governments
Tragedy on the tracks: On the killing of 16 migrant workers
Coming to terms: On India refusing to admit community transmission
The trends shaping the post-COVID-19 world
The epidemic and ensuring safety in courts
Responding to COVID-19 at the grassroots
The face of exploitation
Contempt for labour: On dilution of labour laws
Slower growth and a tighter fiscal
Back home: On return of Indian expatriates
Blame game: On Donald Trump’s anti-China rhetoric over COVID-19
Resuscitating multilateralism with India’s help
A war-like state and a bond to the rescue
Fear and loathing in the land of the free
Everyone wants a good stimulus
Rent control amidst pandemic
Slow release: On lockdown 3.0
No comfort in numbers: On Bengal’s coronavirus cases
Pandemics without borders, South Asia’s evolution
India’s disease surveillance system needs a reboot
No relief for the nowhere people
BRICS against COVID-19
Recovering early: On India’s COVID-19 patients
It’s about food, nutrition and livelihood security
Taiwan’s coronavirus protocol shows how it is done
Needed: a pandemic patent pool
Getty Images/iStockphoto
Plasma therapy is no silver bullet
Take care of yourself too, fellow journalists
Strategic shift: On home isolation of mild coronavirus cases
Coping with today, planning for tomorrow
No end in sight: On India’s coronavirus strategy
Vividly imagining the life of migrant workers
A task for South Asia
Privacy concerns during a pandemic
Unlocking justice in the lockdown
Safe return: On migrant worker distress
The outline of another pandemic combat strategy
Pandemic and panic: On Tamil Nadu’s five-city lockdown
Protecting the poor from becoming poorer
Did SARS-CoV-2 begin from a lab?
Protection for protectors: On safety of healthcare workers
Rapid failures: On antibody testing kits
The COVID-19 paradox in South Asia
Fishing in troubled waters during a pandemic
How will India emerge out of the lockdown?
Making doctors wash hands
Locked out of cities, homes and livelihoods
Script of unity: On coronavirus and social prejudices
Exploiting a pandemic: On Trump’s immigration policy
The village is still relevant
A time for planetary solidarity
There may be no going back
No transparency in West Bengal
Focus on the curve: On India’s COVID-19 numbers
Economy in lockdown: On India’s worst case scenario
A shot of hope with a game changing vaccine
Caught in the heightened arc of communal polemics
Singing the corona tune
Helping a lending hand: On RBI’s second lockdown stimulus
A season of change: On IMD forecast system
A virus, social democracy, and dividends for Kerala
Across the gulf: On stranded Indian workers
Virtual reality: On telemedicine
A blueprint to revive the economy
A case to use JEE-Main instead of JEE-Advanced this year
Will the aviation industry recover from the pandemic?
Data-driven reporting during COVID-19
Stress test: On revised lockdown guidelines
Disastrous decision: On Trump halting funds to WHO
Cease the distractions, seize the moment
Getting the containment strategy in India right
In India’s response, a communications failure
Harmonising with nature
End the harassment of farmers now
A narrowing window: On extension of lockdown
Corona bond: On Eurozone COVID-19 rescue package
Halting the march of rumours
Polls during a pandemic
The pandemic and the contours of a health response
Economic liberalisation and its faults
Invasive, alien, most fearsome
Trade in tatters: On the global slump
Wanted, a collective national endeavour
Disingenuous and no antidote
COVID-19 and the crumbling world order
Women’s safety during lockdown
Lives and livelihoods: On economy after lockdown
Stage fright: On denying community transmission
Team India and winning the pandemic battle
In time of need: On hydroxychloroquine export
Will COVID-19 affect the course of globalisation?
Finding a scapegoat in WHO
Curating news for children during pandemic
A time for extraordinary action
For better use: On MPLADS funds
Needed, greater decentralisation of power
A key arsenal in rural India’s pandemic fight
Preparing for exit: On lifting the lockdown
Sanctions and pandemic: On America’s Iran policy
‘A script of action, responsibility and compassion’: Chief Minister Ashok Gehlot writes on Rajasthan’s fight against COVID-19
Taking a long view of the pandemic fight
Ten questions posed by the virus
A different economic approach
Why healthcare workers above 60 should be ‘benched’
Enemy at the gates: On Kerala-Karnataka border row
Reducing farm distress during a pandemic
Why everyone should wear masks
The criticality of community engagement
A niggardliness that is economically unwarranted
The spectre of a post-COVID-19 world
Light and sound: On Narendra Modi’s 9-minute light ceremony
A million and counting: On global coronavirus spread
Safe forests, safe people: On diseases of animal origin
Quarantine and the law
Making the private sector care for public health
Looking east to contain COVID-19
Limits to rugged individualism
Uncritical endorsement: On exodus of migrant workers and the Supreme Court
Beyond the blame game: On the Tablighi Jamaat episode
A long road: On India’s 21-day coronavirus lockdown
The missing notes: On politics and the fight against COVID-19
China’s zero: On China’s lead in containing coronavirus
Unprecedented step: On Wuhan lockdown
The return of the expert
Lessons from Hubei
A pandemic in an unequal India
Faith can’t override public health
Devising a people-centric response to COVID-19
Karnataka CM writes on how the State is fighting the pandemic
Tamil Nadu CM writes on how the State is stopping the pandemic in its tracks
The hunt for a cure begins with telling the truth
COVID-19 and a city’s anatomy
Long live the nation-state
The COVID cycle
Coronavirus | The worst of times, the best of times
It’s also a fight against punitive measures
The age of the neoliberal virus
The deep void in global leadership
Thinking national, acting local
Every man is a part of the main
Beyond social distancing to fight COVID-19
Next Story